Advice on offers

Hey guys, I am quite conflicted between the two offers. Both offers are right out of undergrad in the UK. I have no plan of getting an MBA. I'm not crazy about PE and would be more interested in public markets (HF/LO). 


A. Eaton Vance (MSIM) Research role (equity) - the team seems nice and more interesting work than IBD. My concern is whether I can do the job well as I didn't have prior research experience. I was wondering what the mobility is like for a LO role (thinking of going to Asia long term). Wouldn't hesitate to take it if it were a tier 1 AM offer but I'm not sure if EV is better than the IBD offer I have. 


B. Top 3 BB IBD - obvious pros and cons. 


Any input is appreciated!

 

EV is a good shop and being added to the MS umbrella will only increase its stance. I think either will give you the same LO/HF exits but IBD will give you more outside of LO/HF (if you change your mind).

If you're not interested, I say save yourself the IBD headache, buyside is most people's end goal. I would guess that switching internally to IBD at MS wouldn't be the hardest if you wanted to change your mind a year or two in

 

Odio qui corporis sint accusantium dolores ex quis. Voluptatem repellat tenetur quae minus provident sit dolorum.

Total Avg Compensation

June 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (22) $375
  • Associates (93) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (69) $168
  • 1st Year Analyst (206) $159
  • Intern/Summer Analyst (149) $101

Leaderboard